Market Now: Nifty Pharma index down; Dr Reddy’s Labs, Biocon top drags

NEW DELHI: Pharma stocks Dr. Reddy’s Laboratories (down 1.27 per cent), Biocon (down 0.76 per cent) and Lupin (down 0.70 per cent) were trading in the red during afternoon trade on Wednesday, keeping the sectoral index down.

The Nifty Pharma was trading 0.34 per cent down at 8,635 around 01:05 pm (IST).

Shares of Cadila Healthcare (down 0.69 per cent), Sun Pharmaceutical Industries (down 0.54 per cent), Aurobindo Pharma (down 0.43 per cent) and Cipla (down 0.43 per cent) were also in the negative territory.

However, shares of of Divi’s Laboratories (up 0.83 per cent), Piramal Enterprises (up 0.51 per cent) and Glenmark Pharmaceuticals (up 0.44 per cent) were trading with mild gains around the same time.

Equity benchmarks slipped into the red as investors were awaiting cues from the RBI’s two-day monetary policy meet.

The NSE Nifty50 index was down 22 points at 10,223, while the BSE Sensex was 57 points down at 33,314.

Among the 50 stocks in the Nifty index, 14 were trading in the green, while 36 were in the red.

Tata Motors, Eicher Motors, Bajaj Finance, Hero MotoCorp and Adani Ports SEZ were among the top gainers in the Nifty index.

However, Titan, HPCL, UPL, BPCL and Indian Oil Corporation were among the top losers of the Nifty team.

  • Related Posts

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi